According to a recent report by Coherent Market Insights, the global Metagenomics Market is estimated to be valued at USD 2.36 Bn in 2025 and is expected to reach USD 4.13 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032. The growing use of metagenomics across diverse industries such as healthcare and biotechnology is expected to drive market growth. Metagenomics offers a wide range of applications, including gene identification for disease treatment, microbiome analysis, biofuel production, and environmental cleanup. Additionally, advancements in sequencing technologies and declining sequencing costs are projected to support the expansion of the metagenomics sector. Increasing global research efforts in this field are also anticipated to further boost market growth during the forecast period.

Request a Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/7489

Global Metagenomics Market Key Takeaways

According to Coherent Market Insights (CMI), the global metagenomics market size is estimated to reach USD 2.36 Bn in 2025 and USD 4.13 Bn by 2032, registering a CAGR of 8.3%.

Based on product, reagents & consumables segment is expected to dominate the industry, accounting for a revenue of about USD 1.30 Bn in 2025.

By technology, shotgun sequencing segment is set to account for more than two-fifths of the global metagenomics market share in 2025.

Based on application, drug discovery segment is likely to hold a market share of 52.8% in 2025

As per Coherent Market Insights’ latest metagenomics market analysis, North America is expected to retain its dominance, accounting for 38% of the global market share in 2025.

Asia Pacific metagenomics market is poised to experience fastest growth during the assessment period.

Rising Prevalence of Chronic and Infectious Diseases Fueling Market Growth

A new report by Coherent Market Insights outlines prominent metagenomics market growth factors. One such growth driver is the increasing incidence of chronic and infectious diseases worldwide.

Rise in chronic and infectious diseases necessitates rapid and accurate identification of pathogens, including rare and complex microbial infections. This is where metagenomics steps in.

Metagenomics offers a powerful tool for identifying novel pathogens as well as analyzing disease-related microbiomes. Thus, rising prevalence of chronic and infectious diseases, coupled with growing demand for enhanced diagnostics technologies, is expected to boost growth of metagenomics market during the forecast period.

Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/7489

High Cost of Sequencing Technologies Restraining Market Growth

The future metagenomics market outlook looks bright. However, high cost of advanced metagenomic sequencing instruments poses a barrier to widespread market expansion.

Sequencing platforms required for advanced metagenomic analysis are quite expensive. This limits their adoption, especially across low- and middle-income regions, thereby reducing overall metagenomics market demand.

Advancements in Genomic Technologies Opening New Growth Opportunities

Ongoing innovations in next-generation sequencing (NGS), shotgun metagenomics, and bioinformatics tools are making metagenomics studies faster as well as more accurate and cost-effective. These technological advancements are expected to unlock new growth opportunities for metagenomics companies during the forecast period.

Impact of AI on the Metagenomics Market

Artificial Intelligence (AI) is emerging as a powerful tool in the metagenomics market. It has the potential to enhance data analysis, pattern recognition, and predictive modeling.

AI tools speed up and improve the analysis of complex microbial data. They help identify new microorganisms, gene functions, and disease links more precisely. This accelerates the discovery of therapeutic targets, environmental monitoring, and microbiome research.

Leading players like Thermo Fisher Scientific and Illumina are increasing this AI trend. For instance, in 2025, Thermo Fisher Scientific launched a new AI-enhanced metagenomics data analytics platform aimed at improving accuracy and speed of microbial classification.

Emerging Metagenomics Market Trends

Growing demand for precision medicine is a key growth-shaping trend in the market. Metagenomics provides insights into the microbiome’s role in health and diseases, thereby enabling the development of targeted therapies.

Many nations are increasingly investing in microbiome research projects like the Human Microbiome Project. This will further boost metagenomics market growth during the forecast period.

Expanding applications in environmental and agricultural microbiology are expected to play a key role in boosting the metagenomics market value. Metagenomics is being widely used to assess microbial diversity in water, soil, and waste treatment systems.

There is also a growing trend of using AI and ML for analyzing vast metagenomic datasets. Such innovations are expected to create lucrative opportunities for metagenomic product manufacturers.

Get Customization on this Report: https://www.coherentmarketinsights.com/insight/request-customization/7489

Analyst’s View

“The global metagenomics industry is expected to experience rapid growth, owing to rising incidence of chronic and infectious diseases, expanding usage of metagenomics in drug discovery, and advancements in genomic technologies,” said senior analyst Abhijeet Kale.

Current Events and Their Impact on the Metagenomics Market

Event	Description and Impact
Post-Pandemic Acceleration of Genome Research Funding	Description: Global research funding for microbiome studies is increasing, with emphasis on infectious disease surveillance and pandemic preparedness. Impact: This drives demand for clinical-grade metagenomic platforms for rapid pathogen detection and variant tracking.
AI & Deep Learning Revolution in Microbiome Analysis	Description: LLMs and AI tools are now being used for microbial functional annotation and strain-level resolution. Impact: These technologies improve the speed and accuracy of interpreting complex metagenomic datasets, enhancing applications across clinical diagnostics, environmental monitoring, and agriculture.
Strategic M&A Activity	Description: In May 2025, Mapmygenome (India) acquired Canadian CRO Microbiome Insights to scale up global sequencing operations. Impact: Such strategic mergers and acquisitions strengthen international presence and diversify service portfolios, fostering market consolidation in the metagenomics sector.

Competitor Insights

Key companies listed in metagenomics market report:

– Illumina, Inc.

– Bio-Rad Laboratories, Inc.

– QIAGEN

– PerkinElmer, Inc.

– Novogene Co., Ltd.

– Thermo Fisher Scientific, Inc.

– Promega Corporation

– Oxford Nanopore Technologies

– Takara Bio, Inc.

– PacBio

– F. Hoffmann-La Roche Ltd

Key Developments

In April 2025, Metabolon introduced the Microbiome Research Solution for high-quality metagenomics and metabolomics data. It combines novel microbiome panel, metagenomics sequencing, and multiomics bioinformatics tools to create the industry’s most powerful microbiome research toolkit.

In July 2024, MGI Tech launched Human Microbiome Metagenomics Sequencing Package. This comprehensive solution encompasses the full workflow of human microbiome metagenomics sequencing, from sample collection and extraction to library preparation, sequencing, and analysis. The package features high automation and flexible throughput.

Market Segmentation

Product Insights (Revenue, USD Bn, 2020 – 2032)

Reagents & Consumables

Instruments

Sequencing & Data Analytics Services

Technology Insights (Revenue, USD Bn, 2020 – 2032)

Shotgun Sequencing

16S Sequencing

Whole Genome Sequencing

Others

Application Insights (Revenue, USD Bn, 2020 – 2032)

Drug Discovery

Clinical Diagnostics

Others

End User Insights (Revenue, USD Bn, 2020 – 2032)

Pharmaceutical Companies

Research Laboratories

Others

Regional Insights (Revenue, USD Bn, 2020 – 2032)

North America

U.S.

Canada

Latin America

Brazil

Argentina

Mexico

Rest of Latin America

Europe

Germany

U.K.

Spain

France

Italy

Russia

Rest of Europe

Asia Pacific

China

India

Japan

Australia

South Korea

ASEAN

Rest of Asia Pacific

Middle East

GCC Countries

Israel

Rest of Middle East

Africa

South Africa

North Africa

Central Africa

About Us:

Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Media Contact
Company Name: Coherent Market Insights
Contact Person: Mr. Raj Shah
Email: Send Email
Phone: 2524771362
Address:533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
City: Burlingame
State: California
Country: United States
Website: https://www.coherentmarketinsights.com/industry-reports/metagenomics-market